Sonidegib as a Locally Advanced Basal Cell Carcinoma Therapy in Real-life Clinical Setting: A National Multicentre Study

• मुख्य लेखकों: O.M. Moreno-Arrones (लेखक), S. Béa-Ardebol (लेखक), F. Mayo-Martinez (लेखक), G. Pérez-Pastor (लेखक), I. Torres-Navarro (लेखक), M. Bonfill-Ortí (लेखक), G. Deza (लेखक), V. Ruiz-Salas (लेखक), E. Masferrer (लेखक), C. Feal (लेखक), L. Turrión-Merino (लेखक), A. Toll (लेखक), M. Yébenes (लेखक), S. Galiano-Mejías (लेखक), A. Jaka (लेखक), C. Ferrandiz-Pulido (लेखक), A. Florez (लेखक), N. Hernández-Hernández (लेखक), R. Fernández- (लेखक), L. Rios-Buceta (लेखक), O. Sanmartin (लेखक)
• स्वरूप: पुस्तक
• प्रकाशित: Elsevier, 2023-07-01T00:00:00Z.
• विषय: article
• ऑनलाइन पहुंच: Connect to this object online.

Background: Basal cell carcinoma (BCC) is the most prevalent cancer. A minority of BCCs have an aggressive behaviour (laBCC) and may require hedgehog pathway inhibitors such as sonidegib as its treatment. Objective: To describe the use of sonidegib in a large number of patients and provide more data...